Dual mTOR/PI3K inhibition specifically prevents the activation of these feedback loops and (Fig. 3G), when applied in early stage disease, this treatment normalizes the renal function and the morphology of ADPKD non-orthologous rat and orthologous mice models. This evidence concerns the gene MTOR and autosomal dominant polycystic kidney disease.